Skip to main content

Advertisement

Log in

Apelin suppresses apoptosis of human osteoblasts

  • Published:
Apoptosis Aims and scope Submit manuscript

Abstract

Objectives: Apelin is a recently discovered peptide that is the endogenous ligand for the orphan G-protein-coupled receptor APJ. Adipocytes can express and secrete apelin. Osteoblast can express apelin and APJ. The aim of this study was to investigate the action of apelin on apoptosis of human osteoblasts. Results: Apelin inhibited human osteoblasts apoptosis induced by serum deprivation. Suppression of APJ with small-interfering RNA (siRNA) abolished the anti-apoptotic activity of apelin. Our study also showed an increased Bcl-2 protein expression and decreased Bax protein expression under the treatment of apelin. Apelin decreased cytochrome c release and caspase-3 activation in human osteoblasts. Apelin activated phosphatidylinositol-3 kinase (PI-3 kinase) and Akt. The apelin-induced activation of Akt was blocked by suppression of APJ with siRNA. LY294002 (a PI-3 kinase inhibitor) or 1L-6-hydroxymethyl-chiro-inositol 2-(R)-2-O-methyl-3-O-octadecylcarbonate (HIMO; an Akt inhibitor) abolished apelin induced activation of Akt, and, LY294002 or HIMO abolished the anti-apoptotic activity of apelin. Furthermore, apelin protects against apoptosis induced by the glucocorticoid dexamethasone. Conclusions: Apelin suppresses serum deprivation-induced apoptosis of human osteoblasts and the anti-apoptotic action is mediated via the APJ/PI-3 kinase/Akt signaling pathway.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Stewart KJ, Deregis RJ, Turner KL et al (2002) Fitness, fatness and activity as predictors of bone mineral density in older persons. J Intern Med 252:381–88

    Article  CAS  PubMed  Google Scholar 

  2. Lim S, Joung H, Shin CS et al (2004) Body composition changes with age have gender-specific impacts on bone mineral density. Bone 35:792–98

    Article  PubMed  Google Scholar 

  3. Lindsay R, Cosman F, Herrington BS, Himmelstein S (1992) Bone mass and body composition in normal women. J Bone Miner Res 7:55–2

    CAS  PubMed  Google Scholar 

  4. Felson DT, Zhang Y, Hannan MT, Anderson JJ (1993) Effects of weight, and body mass index on bone mineral density in men and women. J Bone Miner Res 8:567–73

    CAS  PubMed  Google Scholar 

  5. Glauber HS, Vollmer WM, Nevitt MC, Ensrud KE, Orwoll ES (1995) Body weight versus body fat distribution, adiposity, and frame size as predictors of bone density. J Clin Endocrinol Metab 80:1118–123

    Article  CAS  PubMed  Google Scholar 

  6. Khosla S, Atkinson EJ, Riggs BL, Melton LJ (1996) Relationship between body composition and bone mass in women. J Bone Miner Res 11:857–63

    CAS  PubMed  Google Scholar 

  7. Xie H, Tang SY, Cui RR et al (2006) Apelin and its receptor are expressed in human osteoblasts. Regul Pept 134:118–25

    Article  CAS  PubMed  Google Scholar 

  8. De Mota N, Reaux-Le Goazigo A, El Messari S et al (2004) Apelin, a potent diuretic neuropeptide counteracting vasopressin actions through inhibition of vasopressin neuron activity and vasopressin release. Proc Natl Acad Sci USA 101:10464–0469

    Article  CAS  PubMed  Google Scholar 

  9. Kleinz MJ, Davenport AP (2004) Immunocytochemical localization of the endogenous vasoactive peptide apelin to human vascular and endocardial endothelial cells. Regul Pept 118:119–25

    Article  CAS  PubMed  Google Scholar 

  10. Kawamata Y, Habata Y, Fukusumi S et al (2001) Molecular properties of apelin: tissue distribution and receptor binding. Biochim Biophys Acta 1538:162–71

    Article  CAS  PubMed  Google Scholar 

  11. Habata Y, Fujii R, Hosoya M et al (1999) Apelin, the natural ligand of the orphan receptor APJ, is abundantly secreted in the colostrum. Biochim Biophys Acta 1452:25–5

    Article  CAS  PubMed  Google Scholar 

  12. Tatemoto K, Hosoya M, Habata Y et al (1998) Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. Biochem Biophys Res Commun 251:471–76

    Article  CAS  PubMed  Google Scholar 

  13. Wei L, Hou X, Tatemoto K (2005) Regulation of apelin mRNA expression by insulin and glucocorticoids in mouse 3T3-L1 adipocytes. Regul Pept 132:27–2

    Article  CAS  PubMed  Google Scholar 

  14. Boucher J, Masri B, Daviaud D et al (2005) Apelin, a newly identified adipokine up-regulated by insulin and obesity. Endocrinology 146:1764–771

    Article  CAS  PubMed  Google Scholar 

  15. Lee DK, Cheng R, Nguyen T (2000) Characterization of apelin, the ligand for the APJ receptor. J Neurochem 74:34–1

    Article  CAS  PubMed  Google Scholar 

  16. O’Dowd BF, Heiber M, Chan A et al (1993) A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11. Gene 136:355–60

    Article  PubMed  Google Scholar 

  17. Hosoya M, Kawamata Y, Fukusumi S (2000) Molecular and functional characteristics of APJ: tissue distribution of mRNA and interaction with the endogenous ligand apelin. J Biol Chem 275:21061–1067

    Article  CAS  PubMed  Google Scholar 

  18. Medhurst AD, Jennings CA, Robbins MJ (2003) Pharmacological and immunohistochemical characterization of the APJ receptor and its endogenous ligand apelin. J Neurochem 84:1162–172

    Article  CAS  PubMed  Google Scholar 

  19. Ishida J, Hashimoto T, Hashimoto Y et al (2004) Regulatory roles for APJ, a seven-transmembrane receptor related to angiotensin-type 1 receptor in blood pressure in vivo. J Biol Chem 279:26274–6279

    Article  CAS  PubMed  Google Scholar 

  20. Masri B, Morin N, Cornu M, Knibiehler B, Audigier Y (2004) Apelin (65-77) activates p70 S6 kinase and is mitogenic for umbilical endothelial cells. FASEB J 18:1909–911

    CAS  PubMed  Google Scholar 

  21. Llorens-Cortes C, Beaudet A (2005) Apelin, a neuropeptide that counteracts vasopressin secretion. Med Sci 21:741–46

    Google Scholar 

  22. El Messari S, Iturrioz X, Fassot C, De Mota N, Roesch D, Llorens-Cortes C (2004) Functional dissociation of apelin receptor signaling and endocytosis: implications for the effects of apelin on arterial blood pressure. J Neurochem 90:1290–301

    Article  CAS  PubMed  Google Scholar 

  23. Reaux A, De Mota N, Skultetyova I et al (2001) Physiological role of a novel neuropeptide, apelin, and its receptor in the rat brain. J Neurochem 77:1085–096

    Article  CAS  PubMed  Google Scholar 

  24. Masri B, Lahlou H, Mazarguil H, Knibiehler B, Audigier Y (2002) Apelin (65-77) activates extracellular signal-regulated kinases via a PTX-sensitive G protein. Biochem Biophys Res Commun 290:539–45

    Article  CAS  PubMed  Google Scholar 

  25. Robey PG, Termine JD (1985) Human bone cells in vitro. Calcif. Tissue Int 37:453–60

    Article  CAS  Google Scholar 

  26. Liao EY, Luo XH (2001) Effects of 17beta-estradiol on the expression of matrix metalloproteinase-1,-2 and tissue inhibitor of metalloprotei- nase-1 in human osteoblast-like cell cultures. Endocrine 15:291–95

    Article  CAS  PubMed  Google Scholar 

  27. Luo XH, Guo LJ, Yuan LQ et al (2005) Adiponectin stimulates human osteoblasts proliferation and differentiation via the MAPK signaling pathway. Exp Cell Res 309:99–09

    Article  CAS  PubMed  Google Scholar 

  28. Bodine PVN, Trailamith M, Komm BS (1996) Development and characterization of a conditionally transformed human osteoblastic cell line. J Bone Miner Res 11:806–19

    Article  CAS  PubMed  Google Scholar 

  29. Plotkin LI, Weinstein RS, Parfitt AM, Roberson PK, Manolagas SC, Bellido T (1999) Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin. J Clin Invest 104:1363–374

    Article  CAS  PubMed  Google Scholar 

  30. Ahuja SS, Zhao S, Bellido T, Plotkin LI, Jimenez F, Bonewald LF (2003) CD40 ligand blocks apoptosis induced by tumor necrosis factor alpha, glucocorticoids, and etoposide in osteoblasts and the osteocyte-like cell line murine long bone osteocyte-Y4. Endocrinology 144:1761–769

    Article  CAS  PubMed  Google Scholar 

  31. Zhou N, Fang J, Mukhtar M, Acheampong E, Pomerantz RJ (2004) Inhibition of HIV-1 fusion with small interfering RNAs targeting the chemokine coreceptor CXCR4. Gene Therapy 11:1703–712

    Article  CAS  PubMed  Google Scholar 

  32. De Falco M, De Luca L, Onori N et al (2002) Apelin expression in normal human tissues. In Vivo 16:333–36

    CAS  PubMed  Google Scholar 

  33. Edinger AL, Hoffman TL, Sharron M et al (1998) An orphan seven-transmembrane domain receptor expressed widely in the brain functions as a coreceptor for human immunodeficiency virus type 1 and simian immunodeficiency virus. J Virol 72:7934–940

    CAS  PubMed  Google Scholar 

  34. Wang G, Anini Y, Wei W et al (2004) Apelin, a new enteric peptide: localization in the gastrointestinal tract, ontogeny, and stimulation of gastric cell proliferation and of cholecystokinin secretion. Endocrinology 145:1342–348

    Article  CAS  PubMed  Google Scholar 

  35. Losano GA (2005) On the cardiovascular activity of apelin. Cardiovasc Res 65:8–

    Article  CAS  PubMed  Google Scholar 

  36. Losano G, Penna C, Cappello S, Pagliaro P (2005) Activity of apelin and APJ receptors on myocardial contractility and vasomotor tone. Ital Heart J Suppl 6:272–78

    PubMed  Google Scholar 

  37. Jaszberenyi M, Bujdoso E, Telegdy G (2004) Behavioral, neuroendocrine and thermoregulatory actions of apelin-13. Neuroscience 129:811–16

    Article  CAS  PubMed  Google Scholar 

  38. Sunter D, Hewson AK, Dickson SL (2003) Intracerebroventricular injection of apelin-13 reduces food intake in the rat. Neurosci Lett 353:1–

    Article  CAS  PubMed  Google Scholar 

  39. Sorhede Winzell M, Magnusson C, Ahren B (2005) The APJ receptor is expressed in pancreatic islets and its ligand, apelin, inhibits insulin secretion in mice. Regul Pept 131:12–7

    Article  PubMed  CAS  Google Scholar 

  40. Kasai A, Shintani N, Oda M et al (2004) Apelin is a novel angiogenic factor in retinal endothelial cells. Biochem Biophys Res Commun 325:395–00

    Article  CAS  PubMed  Google Scholar 

  41. Adams JM, Cory S (1998) The Bcl-2 protein family: arbiters of cell survival. Science 258:302–04

    Google Scholar 

  42. Alvarez-Tejado M, Naranjo-Suarez S, Jimenez C, Carrera AC, Landazuri MO, del Peso L (2001) Hypoxia induces the activation of the phosphatidylinositol 3-kinase/Akt cell survival pathway in PC12 cells: protective role in apoptosis. J Biol Chem 276:22368–2374

    Article  CAS  PubMed  Google Scholar 

  43. Barber AJ, Nakamura M, Wolpert EB et al (2001) Insulin rescues retinal neurons from apoptosis by a phosphatidylinositol 3-kinase/Akt-mediated mechanism that reduces the activation of caspase-3. J Biol Chem 276:32814–2821

    Article  CAS  PubMed  Google Scholar 

  44. Almeida M, Han L, Bellido T, Manolagas SC, Kousteni S (2005) Wnt proteins prevent apoptosis of both uncommitted osteoblast progenitors and differentiated osteoblasts by beta-catenin-dependent and -independent signaling cascades involving Src/ERK and phosphatidylinositol 3-kinase/AKT. J Biol Chem 280:41342–1351

    Article  CAS  PubMed  Google Scholar 

  45. Manolagas SC (2000) Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev 21:115–37

    Article  CAS  PubMed  Google Scholar 

  46. Weinstein RS, Jilka RL, Parfitt AM, Manolagas SC (1998) Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids: potential mechanisms of their deleterious effects on bone. J Clin Invest 102:274–82

    Article  CAS  PubMed  Google Scholar 

  47. Weinstein RS, Nicholas RW, Manolagas SC (2000) Apoptosis of osteocytes in glucocorticoid–induced osteonecrosis of the hip. J Clin Endocrinol Metab 85:2907–912

    Article  CAS  PubMed  Google Scholar 

  48. O′Brien CA, Jia D, Plotkin LI et al (2004) Glucocorticoids act directly on osteoblasts and osteocytes to induce their apoptosis and reduce bone formation and strength. Endocrinology 145:1835–841

    Article  PubMed  CAS  Google Scholar 

  49. Gohel A, McCarthy MB, Gronowicz G (1999) Estrogen prevents glucocorticoid-induced apoptosis in osteoblasts in vivo and in vitro. Endocrinology 140:5339–347

    Article  CAS  PubMed  Google Scholar 

  50. Owen M (1988) Marrow stromal stem cells. J Cell Sci 10:63–6

    CAS  Google Scholar 

  51. Prockop DJ (1997) Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276:71–4

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Er-Yuan Liao.

Additional information

Hui Xie and Ling-Qing Yuan both authors contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Xie, H., Yuan, LQ., Luo, XH. et al. Apelin suppresses apoptosis of human osteoblasts. Apoptosis 12, 247–254 (2007). https://doi.org/10.1007/s10495-006-0489-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10495-006-0489-7

Keywords

Navigation